Agrees to Repurchase of All Shares Held By ADAR1 Capital Management and Pontifax Venture Capital
Keros Therapeutics Announces Plan for Return of $375 Million in Excess Capital
Seeking Alpha / 21 hours ago 3 Views
Seeking Alpha / 21 hours ago 3 Views
Agrees to Repurchase of All Shares Held By ADAR1 Capital Management and Pontifax Venture Capital
Comments